We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Immunicom presented preliminary data from a clinical trial investigating a potential therapy for resistant melanoma and other solid cancers using an external blood-filtering device, showing that the treatment is safe and well-tolerated. Read More
Venus Medtech (Hangzhou) has expanded its reach into transcatheter mitral and tricuspid valve treatments with the purchase of Cardiovalve, an Israel-based devicemaker that specializes in such products. Read More
The FDA has granted premarket approval to Thermo Fisher Scientific's Oncomine Dx Target Test as a companion diagnostic to help identify nonsmall-cell lung cancer (NSCLC) patients whose tumors carry certain mutations for potential treatment with Rybrevant (amivantamab-vmjw), Janssen’s targeted therapy. Read More
Several recent lung cancer clinical trials combining radiotherapy with drug therapy demonstrate significant improvements in overall and progression-free survival, the company said. Read More
If present in the sample, RNA from the SARS-CoV-2 virus that causes COVID-19 infection is detected using an approved molecular diagnostic test. Read More
Testing to support the FDA submission included patients with conditions, such as chronic respiratory pulmonary disease, asthma, congestive heart failure and anxiety, the company said. Read More
Members of Congress from both parties have asked the Centers for Medicare and Medicaid Services (CMS) to take action to deal with “preventable error” leading to false-positive results from blood tests used in the diagnosis of sepsis. Read More
The FDA’s proposed rule on over-the-counter (OTC) hearing aids does not introduce a new device classification, but is more “like a rule of the road,” explained Ian Ostermiller, policy adviser in the FDA’s Office of Policy, during a Tuesday webinar hosted by the agency. Read More